Study wrapper · #1195
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Editor's note
Early-stage medicinal chemistry: stability was measured, function was only modelled. Improved serum and proteolytic stability relative to semaglutide is a real result, but without receptor-activation or in vivo data it says nothing about potency or duration of effect. Relevant as a window into where next-generation GLP-1 peptide design is heading.
Plain-language abstract
Chemists took the short segment of semaglutide that engages the GLP-1 receptor and rebuilt it as a stapled peptide - a chemical bridge that locks the molecule into its active shape - designing 108 candidates and synthesising 35 of them. Most of the stapled versions survived longer in serum and resisted enzymatic breakdown better than semaglutide itself, with three standing out. Computer simulations suggested the best candidates still fit the receptor, but no cell or animal activity data are reported.